Skip to content

NOVIDAT Tablets

NOVIDAT Tablets (Ciprofloxacin HCL) USP Specs, by SAMI, are 500 mg, 10 tablets. It is used to treat bacterial infections, including urinary tract infections (UTIs), certain respiratory tract infections, gastrointestinal infections such as bacterial diarrhea and typhoid fever, and skin, bone, and joint infections.

Package Contains: Each NOVIDAT Tablet package contains 10 tablets of 500mg. It is also available as 250mg tablets and as a 125mg/250mg oral suspension.  NOVIDAT Tablets

Composition: Each film-coated tablet contains:

Ciprofloxacin Hydrochloride USP equivalent to

Ciprofloxacin 500mg

Dosage: One tablet twice daily or as directed by the physician. For oral use only.

Indications/ Uses: NOVIDAT 500mg film-coated tablets are indicated for the treatment of the

following infections.

Adults:

  • Lower respiratory tract infections due to Gram-negative bacteria: Exacerbations of chronic obstructive pulmonary disease. In exacerbation of chronic obstructive pulmonary disease, ciprofloxacin should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections; broncho-pulmonary infections in cystic fibrosis or in bronchiectasis; pneumonia.
  • Chronic suppurative otitis media.
  • Acute exacerbation of chronic sinusitis, especially if these are caused by Gram-negative bacteria.
  • Urinary tract infections: Uncomplicated acute cystitis. In uncomplicated acute cystitis, ciprofloxacin should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections, Acute pyelonephritis, Complicated urinary tract infections, and bacterial prostatitis.
  • Genital tract infections: Gonococcal urethritis and cervicitis due to susceptible Neisseria gonorrhoeae, Epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae, Pelvic inflammatory disease including cases due to susceptible
  • Neisseria gonorrhoeae.
  • Infections of the gastrointestinal tract (e.g., travelers’ diarrhoea).
  • Intra-abdominal infections.
  • Infections of the skin and soft tissue caused by Gram-negative bacteria.
  • Malignant external otitis.
  • Infections of the bones and joints.
  • Prophylaxis of invasive infections due to Neisseria meningitides.
  • Inhalation anthrax (post-exposure prophylaxis and curative treatment).

Ciprofloxacin may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection. Children and adolescents:

Children and adolescents:

  • Broncho-pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.
  • Complicated urinary tract infections and pyelonephritis.
  • Inhalation anthrax (post-exposure prophylaxis and curative treatment). Ciprofloxacin may also be used to treat severe infections in children and adolescents when this is considered to be necessary.
  • Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents.

Undesirable Effects: The most commonly reported adverse drug reactions (ADRs) are nausea and diarrhoea. ADRs derived from clinical studies and post-marketing surveillance with Ciprofloxacin (oral, intravenous, and sequential therapy) sorted by categories of frequency are listed below. The frequency analysis takes into account data from both oral and intravenous administration of ciprofloxacin. Adverse reactions are ranked by system organ class and then by frequency with the most frequent first, using the following convention: Common (≥ 1/100 to <1/10); Uncommon (≥ 1/1,000 to < 1/100); Rare (≥1/10,000 to <1/1000); Very Rare (1/10,000); Not known (cannot be estimated from the available data)

  • Infections and Infestations: Uncommon: Mycotic super infections.
  • Blood and lymphatic system disorders: Uncommon: Eosinophilia.

Rare: Leukopaenia, anaemia, neutropaenia, leukocytosis, thrombocytopaenia.

Very Rare: Haemolytic anaemia, agranulocytosis, pancytopaenia (life-threatening), bone marrow depression (life-threatening).

  • Immune system disorders: Rare: Allergic reaction, allergic oedema/ angioedema.

Very rare: Anaphylactic reaction, anaphylactic shock (life-threatening), serum sickness-like reaction.

  • Endocrine disorders: Not known: Syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
  • Metabolism and Nutrition Disorders: Uncommon: Decreased appetite.

Rare: Hyperglycaemia, hypoglycaemia.

Not Known: Hypoglycaemic coma.

  • Psychiatric Disorders: Uncommon: Psychomotor hyperactivity/ agitation.

Rare: Confusion and disorientation, anxiety reaction, abnormal dreams, Depression (potentially culminating in suicidal ideations/ thoughts or suicide attempts and completed suicide), hallucinations.

Very Rare: Psychotic reactions (potentially culminating in suicidal ideations/ thoughts or suicide attempts and completed suicide).

Not Known: Mania, incl. hypomania

  • Nervous system disorders: Uncommon: Headache, dizziness, sleep disorders, taste disorders.

Rare: Paraesthesia and Dysaesthesia, hypoaesthesia, tremor, seizures (including status epilepticus), vertigo.

Very Rare: Migraine, disturbed coordination, gait disturbance, olfactory nerve disorders, intracranial hypertension and pseudotumor cerebri.

Not Known: Peripheral neuropathy and polyneuropathy.

  • Renal and urinary disorders: Uncommon: Renal impairment

Rare: Renal failure, haematuria, crystalluria, tubulo-interstitial nephritis.

Contraindications:

  • Hypersensitivity to the active substance, to other quinolones or to any of the excipients.
  • Concomitant administration of ciprofloxacin and tizanidine.

Warning: Only to be sold on prescription of a registered medical practitioner.

Instructions: Keep out of reach of children. Avoid exposure to heat, light and humidity Store between 15 to 30°C. Improper storage may deteriorate the medicine. NOVIDAT Tablets back

Manufacturer & Buy Online:

NOVIDAT tablets are manufactured by: SAMI Pharmaceuticals (Pvt.) Ltd.

For more information, this is the link to the manufacturer: https://samipharma.com

You can buy it online at:  https://www.dvago.pk

You can buy it from any nearby pharmacy. As of 2026, it is available at a retail price of around 422 rupees.

 

By: Urooj

Tags: